StocksMedium•3 November 2026•
1 min read
AbbVie Hits New All-Time High After Raising Financial Guidance
Key Facts
1AbbVie shares have recorded a 33% gain for the year, reaching a new all-time high.
2The company raised its financial guidance again following strong earnings results.
AbbVie shares have recorded a 33% gain for the year, reaching a new all-time high. 247wallst.com reported that the company raised its financial guidance again following strong earnings results, lifting its full-year adjusted EPS forecast to a range of $13.95 to $13.99.
ABBV closed at $288.94 on November 2, 2026, prior to hitting its latest record levels. The rally was fueled by performance in the immunology portfolio, where Skyrizi and Rinvoq generated a combined $8.48 billion in quarterly revenue, alongside a 19.4% rise in neuroscience sales according to 247wallst.com.